Treatment of slow-channel congenital myasthenic syndrome in a Thai family with fluoxetine

Journal of Clinical Neuroscience(2022)

Cited 1|Views8
No score
Abstract
•The slow-channel congenital myasthenic syndrome (SCCMS) is a rare neuromuscular disorder.•Fluoxetine is effective in the treatment of SCCMS.•All patients showed progressive improvement in their muscle power and endurance.
More
Translated text
Key words
Slow-channel congenital myasthenic syndrome,Treatment,Thai,Fluoxetine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined